Merck Group

Merck Group

Pharmaceutical Manufacturing

We are Merck, a vibrant science and technology company. Science is at the heart of everything we do.

About us

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Website
http://www.merckgroup.com
Industry
Pharmaceutical Manufacturing
Company size
10,001+ employees
Headquarters
Darmstadt
Type
Public Company
Founded
1668
Specialties
Pharmaceuticals, Chemicals, Technology, and Science

Locations

Employees at Merck Group

Updates

  • Merck Group reposted this

    View profile for Belén Garijo
    Belén Garijo Belén Garijo is an Influencer

    Chair of the Executive Board and CEO of Merck

    In recent conversations with my family, colleagues, and industry peers in Germany but also across Europe, there has been one recurring topic – we are all witnessing an alarming rise of populism, protectionism, and a decline in solidarity. A recent Global Risk Report 2024 launched by the World Economic Forum highlighted 'societal polarization' as one of the top global risks facing our world. This underscores the urgency to unite, consider the bigger picture, work in support of international collaboration, while respecting and role-modeling our democratic principles. And these shouldn’t be negotiable. My aspiration for an inclusive world starts with upholding our commitment to core European values. Democracy, freedom, equality, and human rights are and must remain the core of our identity. These values are not only the foundation of our society but also provide the fertile ground for innovation, growth, and competitiveness. The key here is to further nurture the power of diversity to build a stronger and more united Europe. 

    • No alternative text description for this image
  • View organization page for Merck Group

    1,168,585 followers

    As 2023 draws to a close, we want to take a moment to look back at a year of transformation and progress, and the achievements that characterized 2023 and will continue to shape our work in the future. We want to say thank you to our community, our employees and all the people who share our love and passion for science and technology.   📖 Join us in revisiting the highlights of 2023 in this article!   #2023 #YearEnd #Recap

    Looking back at 2023

    Looking back at 2023

    Merck Group on LinkedIn

  • View organization page for Merck Group

    1,168,585 followers

    Exciting News! 🌟 We are thrilled to announce that we are ranked 68th in this year's prestigious Forbes list of the World's Best Employers! 🎉 At Merck, we prioritize creating a positive and empowering work environment, fostering growth, and embracing diversity and innovation. This accomplishment reaffirms our commitment to our employees and their well-being. Thank you to all our incredible employees who contribute to our success every day! 🙏   #ForbesWorldsBestEmployers #MakingADifference #TeamMerck https://lnkd.in/dz9QPgR9

    The World's Best Employers 2023

    The World's Best Employers 2023

    forbes.com

  • View organization page for Merck Group

    1,168,585 followers

    As part of yesterdays world mental health day, we are proud to announce the launch of BeHealthy, our new global employee health program designed to support and encourage physical, mental, and social wellbeing. At Merck, we recognize that our employees are our most important strength, and investing in their health and wellbeing is crucial to our success. Our program offers a wide range of opportunities and resources to support employees in their individual health journeys such as physical activities, nutrition counseling, mental health support, and stress-management techniques. BeHealthy is not just a mere collection of initiatives; it represents a cultural shift within our organization and fuels our High-Impact Culture. We believe that investing in our employees' health and well-being not only benefits them as individuals but ultimately contributes to our collective success as a company. Join us in fostering a workplace where employees can flourish and be the best versions of themselves. Let's prioritize our health together. #BeHealthy #EmployeeWellbeing #WorldMentalHealthDay #MentalHealthAwareness Peter Guenter Merck Healthcare Patrick Metz Yvonne Romina Demir Mike Jackson Ruth Effenberger Julie Jiayu Fu Sagar Jadhav Helea Lais Soares Ferreira Aïcha Rivollet Manuela Arnold James Hipkin Dr. med. Sven Bohlmann Neil Perrett Lisa Weinacht Manel Khalfaoui Polina Novikova 刘佳洁 Rosalin K. Markus Thong

  • Merck Group reposted this

    View profile for Belén Garijo
    Belén Garijo Belén Garijo is an Influencer

    Chair of the Executive Board and CEO of Merck

    We unreservedly condemn this weekend’s brutal terrorist attack on Israel, which is bringing so much pain, violence, and suffering. We sincerely hope this conflict is resolved quickly and sustainable peace can be achieved for everyone. To our more than 400 colleagues in Israel, we are grateful you are safe. We stand resolutely with you. Your safety, and that of your families, will remain our highest priority as we continue to closely monitor the situation.  For more than 54 years, Merck has stood proudly alongside the people of Israel to build an ecosystem of tremendous innovation and resilience. To our many customers, partners, and friends, please be assured that our support and confidence in you is unwavering. On behalf of the Executive Board of Merck Group

  • View organization page for Merck Group

    1,168,585 followers

    Join us in congratulating our CEO Belén Garijo on being once again named one of Fortune's Most Powerful Women this year! This prestigious recognition honors 100 inspiring female leaders in business, cultural, political and society who are breaking barriers and paving the way for future generations. 👉https://lnkd.in/gYhtz6f8 #FortuneMPW #WomenInLeadership #LeadershipGoals

    Belén Garijo | 2023 Most Powerful Women

    Belén Garijo | 2023 Most Powerful Women

    fortune.com

  • View organization page for Merck Group

    1,168,585 followers

    Great science receives great acknowledgement! Congratulations to Katalin Karikó and Drew Weissman for jointly winning the 2023 Nobel Prize in physiology / medicine “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against Covid-19“ Their pioneering research helped lay the essential groundwork for the rapid development of mRNA vaccines by BioNTech and others during the Covid-19 #pandemic. Their ongoing research efforts are continuing to now help the biopharma industry create an exciting new wave of mRNA medicines to treat a variety of chronic diseases.  The receipt of the Nobel Prize by Kariko and Weissmann is another great example of how science can advance human progress for all. On our end, we are proud to continue serving as an enabling provider of solutions to develop and manufacture #mRNA-based therapeutics and vaccines for many customers, including as a supplier of lipids to partners such as BioNTech SE. #innovation #science #nobelprize

    View organization page for The Nobel Prize

    736,759 followers

    BREAKING NEWS The Nobel Assembly at Karolinska Institutet has today decided to award the 2023 Nobel Prize in Physiology or Medicine to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.   The discoveries by the two Nobel Prize laureates were critical for developing effective mRNA vaccines against COVID-19 during the pandemic that began in early 2020. Through their groundbreaking findings, which have fundamentally changed our understanding of how mRNA interacts with our immune system, the laureates contributed to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times. Learn more Press release: https://bit.ly/3LyuMgU Advanced information: https://bit.ly/454TWdZ

    • No alternative text description for this image
  • View organization page for Merck Group

    1,168,585 followers

    Have you always wanted first-hand tips for your next job application? On this Global Talent Acquisition Day, we celebrate our HR professionals by asking them for their expertise. Watch our insightful conversation with Stefan Jeschke, Senior Global Talent Advisor, and Theodora Coban, Go Global Trainee in HR. They share their insights about application processes and their top tips for your next job interview. Here, you can find all open positions at Merck: come2Merck.com #WorkYourMagic #Recruiting #HiringProcess #career #application #GlobalTalentAcquisitionDay #GlobalTADay

  • Merck Group reposted this

    View profile for Belén Garijo
    Belén Garijo Belén Garijo is an Influencer

    Chair of the Executive Board and CEO of Merck

    Today, at our Merck Group Townhall, I checked in with our global team to discuss our strong position, outlook, and growth priorities. Here are my three top takeaways:    1. We continue to overcome adversity for those we serve.  The last few years have been tough. For us at Merck, it's been no different. And yet, we have continued to step up in countless ways for customers, patients, society, and each other. Our valuable contributions worldwide are being frequently recognized by those we serve. I, for one, could not be prouder!   2. Our leadership position remains strong despite market headwinds. Thanks to our resilience, our Group position today is strong. After successfully riding some favorable tailwinds, we are now adapting to navigate our way through some short-to-mid-term headwinds. During the townhall, we defined the priorities that will define our collective success moving forward.   3. We are on track to reshape Merck for an even greater impact tomorrow. I've said it before: Change is the only constant! Leaders have a choice: Evolve or get left behind. Given our growth trajectory and the megatrends transforming society, a unique growth opportunity stands before us at Merck. As CEO, it is my responsibility to ensure we're ready to seize this moment. So far, we're heading in the right direction and I feel very confident in our long-term future. Thank you to everyone who is breaking down their siloes and stepping outside their comfort zone to unlock our ONE Merck potential. Let us continue to “walk the talk” by leading with purpose and owning the outcome. 

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image

Affiliated pages

Similar pages

Browse jobs

Funding

Merck Group 1 total round

Last Round

Grant

US$ 2.8M

See more info on crunchbase